Edition:
United States

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,673.00GBp
14 Dec 2018
Change (% chg)

15.50 (+0.33%)
Prev Close
4,657.50
Open
4,630.00
Day's High
4,688.50
Day's Low
4,630.00
Volume
5,974,635
Avg. Vol
2,732,361
52-wk High
4,827.75
52-wk Low
2,940.50

Select another date:

Wed, Dec 5 2018

UPDATE 4-Takeda clears key hurdle as investors back $59 billion Shire deal

* Shares in Shire and Takeda both gain ground (Updates with approval from Shire shareholders)

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

EU mergers and takeovers (Nov 20)

BRUSSELS, Nov 20 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS, Nov 20 The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON, Nov 20 Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire, dealing a blow to a group of investors who hope to block the deal.

EU mergers and takeovers (Nov 16)

BRUSSELS, Nov 16 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON, Nov 12 Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire, according to documents for the deal published on Monday.

Select another date: